Everyone who navigates the complexities of cancer care wants the same thing: to achieve better outcomes for patients. We help you make that possible for the people you treat. When that means advancing therapies through cancer research, we lead it. When that means enhancing care with trusted technology, we enable it. When that means discovering a new insight, we help unlock it. We’re here because it means something to us—and we keep improving because it means everything to your patients.

As a national leader in cancer research, we take our work seriously. The Network is proud to have an expansive reach and clinical trial menu through our research partner Sarah Cannon Research Institute (SCRI), with the 31 states in The Network bringing greater accessibility and convenience to patients. Practices in The Network have access to the most advanced clinical trials available today with SCRI—giving providers the opportunity to advance therapies and personalize treatment for patients in their local communities. With The Network and SCRI you can benefit from expertise in trial operations, freeing your practice to focus on care delivery, and improving accessibility to advanced treatment options.  We are dedicated to expanding pioneering research and treatment approaches through collaboration with SCRI, with more than 1,300 providers in clinical research studies at more than 250 locations across the US.[1]